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Abstract
Introduction: Mycobacterium tuberculosis may cause a large variety of clinical presentations due to
its ability to disseminate by contiguity or hematogenously. Tuberculosis may remain undiagnosed
for years due to the chronic course of the disease, with potentially life-threatening long-term
complications.
Case presentation: In this case report, we describe a tuberculous aortic graft infection in a 72-
year-old man documented by polymerase chain reaction and cultures. The patient presented with
three episodes of hemoptysis following a remote history of miliary tuberculosis. The infection was
treated by graft replacement and prolonged antimycobacterial therapy.
Conclusion: Tuberculous infection of a vascular graft is an uncommon complication, but should
be considered in patients with an intravascular device and a history of previous tuberculosis,
especially when hematogenous spread may have occurred a few months after surgery, or when an
active mycobacterial infection is present in close proximity to the graft.
Introduction
Mycobacterium tuberculosis is a common pathogen that
may cause a large variety of clinical presentations due to
its ability to disseminate by contiguity or hematoge-
nously. Tuberculosis may remain undiagnosed for years
due to the chronic course of the disease, with potentially
life-threatening long-term complications. Here, we report
a case of mycobacterial aortic graft infection documented
by both polymerase chain reaction (PCR) and culture and
we review the literature.
Case presentation
A 72-year-old man with chronic alcohol abuse and hyper-
tension, and who had been a smoker, had had past surgi-
cal interventions for atherosclerotic vascular disease
(bilateral iliofemoral bypass and abdominal aortic aneu-
rysm repair). In April 2001, the patient presented with
severe chest pain due to a descending thoracic aortic aneu-
rysm. At that time, there was no lung abnormality
revealed by a computed tomography (CT) scan of the
chest. A thoracotomy was performed and a Dacron pros-
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rysm and he had an uncomplicated postoperative course.
Six months later, the patient was hospitalized because of
weight loss, night sweats, a dry cough and progressive dys-
pnea for the past 4 weeks. Chest radiography and CT
showed bilateral interstitial lung infiltrates with miliary
appearance. No cavitation was documented. A diagnostic
bronchoscopy was performed. A Ziehl-Neelsen examina-
tion of the lower respiratory tract samples was positive for
acid-fast bacilli. PCR and culture of the bronchoalveolar
lavage fluid revealed the presence of M. tuberculosis.
Hematogenous dissemination of M. tuberculosis was con-
firmed by a concomitant positive urine culture. Treatment
with rifampicin and isoniazid for 6 months, plus pyrazi-
namide and ethambutol during the first 2 months was
given as directly observed therapy, since the strain isolated
in culture was susceptible to all major antimycobacterial
drugs.
Three weeks later, the patient presented with massive
hemoptysis and severe bronchoaspiration requiring intu-
bation and cardiopulmonary resuscitation. Repeated
bronchoscopies documented persistent bleeding from the
left lower lobe bronchus. Despite the possible occurrence
of a fistula between the aorta and the bronchial tree, the
treatment was medical since a chest CT scan did not con-
firm the presence of a fistula. As bleeding resolved spon-
taneously, hemoptysis was suspected to be only due to
lung tuberculosis and not to aortic involvement. Conse-
quently, the patient was not referred for angiography.
Two months later, the patient presented with a recurrence
of hemoptysis of about 300 ml while coughing. Bronchos-
copy showed blood clots at the orifice of the left lower
lobe bronchus. A CT scan confirmed the hypothesis of an
aorto-pulmonary fistula by the presence of a hematoma
around the distal anastomosis of the aortic graft and con-
trast enhancement in the anterior wall of the thoracic
descending aorta. Despite the absence of active bleeding
at the aortography, an endoprosthesis (Talent type 10 cm)
was inserted around the level of the distal anastomosis.
Five days later, another bronchoscopy did not show any
further bleeding. The bronchial tree appeared normal on
endobronchial inspection, and no mycobacteria could be
grown from the bronchoalveolar lavage. Consequently,
the fistula was not attributed to an uncontrolled infection.
Antimycobacterial treatment was continued for about 3
months after this second episode of hemoptysis. The
patient was then lost to follow-up and the evolution of the
periaortic hematoma could not be monitored.
The patient remained asymptomatic until October 2006,
when he developed recurrent hemoptysis. CT scan
showed air anterior to the vascular graft (Figure 1A),
strongly suggestive of an aorto-pulmonary fistula. Bron-
choscopy again revealed bleeding originating from the left
lower lobe bronchus. A prosthetic infection was sus-
pected. The graft was surgically replaced in November
2006, using a rifampicin-soaked gelatin-sealed polyester
graft, after a transaortic debridement of the inside of the
aneurysm. At the time of the operation, culture of the
bronchoalveolar lavage fluid was still negative for M.
tuberculosis but turned positive 2 weeks later. On a frag-
ment of the removed prosthesis (Figure 1B), acid-fast
bacilli were seen on microscopic examination. Real-time
PCR specific for M. tuberculosis and culture of the endo-
prosthesis later returned positive for M. tuberculosis. On a
scraping of the prosthesis, inflammatory cells were seen
(Figure 1C), and Ziehl-Neelsen staining was positive for
acid-fast bacilli (Figure 1D). This M. tuberculosis infection
of the vascular graft, which was responsible for the fistula
and secondary hemoptysis, was treated with rifampicin,
isoniazid, pyrazinamide and ethambutol. Two months
later, given the antibiotic susceptibility of the strain, only
rifampicin and isoniazid were continued. The patient's
clinical course remained favorable at the last follow-up 9
months after surgery.
Discussion
Here we report a PCR and culture-proven case of M. tuber-
culosis vascular graft infection that presented with recur-
rent hemoptysis. The infection may have been due to
hematogenous spread or to direct extension from contig-
uous lung infection. The first hypothesis is supported by
the occurrence of a miliary tuberculosis 6 months after
aortic aneurysm surgery. However, the second hypothesis
is more likely given the localization of lung infection near
to the aorta and the documented aortopulmonary fistula.
To the best of our knowledge, only four other cases of M.
tuberculosis vascular graft infections have been reported to
date. The first case was described in 1977 by Wright et al.
[1]. Three years after prosthetic aortic graft placement, dis-
ruption of the proximal aortic suture and a large pseudo-
aneurysm developed. Complete graft excision was
required, followed by prolonged antituberculous treat-
ment. Marroni et al. [2] reported the case of an 80-year-
old man with fever of unknown origin that was attributed
to endovascular aortic graft M. tuberculosis infection. Inter-
estingly, the evolution was complicated by an aorto-
esophageal fistula. Raffetto et al. [3] described an aortob-
ifemoral Dacron graft infection occurring 2 years after a 6-
month course of isoniazid for treatment of latent tubercu-
losis in an immunocompromised patient who had been
treated with high-dose corticosteroids plus infliximab for
Takayasu arteritis. A recent report by Sirvanci et al. [4]
describes a case of recurrent false aneurysm of the
descending thoracic aorta after surgical treatment by exci-Page 2 of 4
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Radiographic, pathological and microbiological findingsFigure 1
Radiographic, pathological and microbiological findings. (A) Computed tomography (CT) showing the presence of an 
air bubble anterior to the vascular graft, suggesting an aorto-pulmonary fistula. (B) Surgically excised Dacron prosthesis from 
which Mycobacterium tuberculosis DNA was amplified and M. tuberculosis grew in culture. (C) Inflammatory cells on a scraping of 
the prosthesis. No granuloma formation is seen (hematoxylin eosin staining). (D) Ziehl-Neelsen staining of the scraping of the 
prosthesis showing numerous acid-fast bacilli.
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was not proven.
Aortic aneurysms are rare complications of tuberculosis.
From 1950 to 1995, only 41 cases of aortic mycotic aneu-
rysm caused by M. tuberculosis have been reported [5].
Approximately 75% of cases were consecutive to a contig-
uous focus of tuberculosis (lymph nodes, lung, vertebrae
or paraspinal abscess) whereas 25% of cases were consid-
ered to be of hematogenous origin. Several reports have
described hemoptysis consecutive to a bronchial commu-
nication with a tuberculous aortic aneurysm [6-8]. The
accepted treatment of a tuberculous vascular aneurysm is
a combination of surgery and antimycobacterial therapy
[9-11]. Neither medical nor surgical therapy leads to cure,
if used alone [5]. Recently, it was suggested that endovas-
cular treatment for tuberculous infected aneurysm may
lead to life-threatening recurrences, because of the
absence of tissue debridement [12]. The optimal duration
of treatment is unknown because of the lack of controlled
trials. Pre-operative antituberculous therapy may decrease
the risk of infection of the implanted graft. Interestingly,
medical therapy for tuberculosis might not prevent the
development of a tuberculous aneurysm [10].
The case of graft infection reported by Raffetto et al. [3]
was successfully managed by performing debulking sur-
gery followed by long-term antimycobacterial therapy.
Thus, graft preservation also seems to be possible with
long-term suppressive therapy.
Consequently, we decided to treat the patient for at least
1 year after surgery. Whether the treatment might be
stopped at that time will be decided based on clinical evo-
lution, inflammatory parameters (C-reactive protein
(CRP), leukocyte count) and radiological imaging. After
stopping treatment, we propose to measure CRP and leu-
kocyte count regularly and to repeat a chest CT scan twice
a year at least for the next 2 years in order to detect a pos-
sible recurrence.
Conclusion
Tuberculous infection of a vascular graft is an uncommon
complication, but our case suggests that it should be con-
sidered in patients with an intravascular device and a his-
tory of previous tuberculosis, especially when
hematogenous spread may have occurred a few months
after surgery or when an active mycobacterial infection is
present in close proximity to the graft.
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